Xaira Therapeutics

Xaira is pioneering the use of artificial intelligence and machine learning to fundamentally transform how we discover and develop medicines. Founded by revolutionaries in biotechnology – Nobel Laureate David Baker, Bob Nelsen of ARCH Venture Partners, and Vik Bajaj of Foresite Capital – and backed by over $1 billion in funding, Xaira has assembled the most advanced technology, deepest expertise, and boldest vision to lead this transformation. We're tackling the complete drug development process: identifying the right molecular target, designing effective drugs, and matching them to the right patients – activities plagued by staggering failure rates, decade-long timelines, and multi-billion dollar costs. Our mission is to transform this trial-and-error endeavor into an engineering discipline that will usher in a new era of precision medicine.